EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY-NC-ND 4.0

Global disparities in cystic fibrosis outcomes prior to CFTR modulators: A CF registries cohort study in South Africa and Canada

Marco Zampoli, Jenna Sykes, Janine Verstraete, Stephanie Y Cheng, Brenda Morrow, Michael S Pepper, Cheryl Stewart, Heather J Zar, Anne L Stephenson

Journal of Cystic Fibrosis · 2024-03 · 23 (2) · 334-340

DOI: 10.1016/j.jcf.2023.09.003 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Journal of Cystic Fibrosis, 2024-03. Verfasst von Marco Zampoli und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Paediatrics and Child Health, University of Cape Town, South Africa; South African MRC Unit for Child and Adolescent Health, University…. Hauptthemen laut MEDLINE: Cystic Fibrosis, Registries, Cystic Fibrosis Transmembrane Conductance Regulator. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Harry Crossley Foundation, Cystic Fibrosis Foundation, National Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Outcomes of cystic fibrosis (CF) differ between low-middle income and high-income countries, but comparative data are lacking. We compared South African (SA) and Canadian CF outcomes to explore what disparities existed prior to access of CFTR modulators in Canada. METHODS: A cross-sectional study of SA and Canadian CF registries data for period 1 January to 31 December 2018. CF registry data were harmonised between countries to compare lung function and nutrition outcomes. Poor nutrition was defined as BMIz-score 10 was considered significant. RESULTS: After excluding Canadians on CFTR modulators and lung transplant recipients, data on 4049 Canadian and 446 SA people was analysed. Compared to Canada, people in SA were younger (median age 15.8 years vs. 24.1 years: SMD 52) with fewer males (47.8% vs 54.2%; SMD 12.5) and White (70.9% vs. 93.3%; SMD 61.3). Class I-III CFTR mutation frequency was similar in SA (n = 384, 86.1%) and Canada (n = 3426, 84.9%). After adjusting for age, gender, diagnosis age, genotype, P.aeruginosa infection and pulmonary treatments, FEV1pp was 8.9% lower (95% CI 6.3% to 11.4%) and poor nutrition 1.7-fold more common (OR 1.70; 95% CI 1.19-2.41) in SA compared to Canada. CONCLUSION: Lung function and nutrition was significantly lower in SA compared to Canada. Global disparities in CF outcomes between high and low-middle income countries are likely to widen as CFTR modulators are rapidly scaled up in only high-income countries.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cystic FibrosisRegistriesCystic Fibrosis Transmembrane Conductance RegulatorHumansSouth AfricaCanadaMaleFemaleCross-Sectional StudiesAdolescentAdultYoung AdultChildHealthcare DisparitiesCohort Studies

Stichwörter der Autor:innen

CanadaCystic fibrosisOutcome disparitiesSouth Africa

Substanzen

Cystic Fibrosis Transmembrane Conductance Regulator

Autor:innen und Institutionen

  • Department of Paediatrics and Child Health, University of Cape Town, South Africa; South African MRC Unit for Child and Adolescent Health, University of Cape Town, South Africa. Electronic address: m.zampoli@uct.ac.za.
  • Department of Respirology, Adult Cystic Fibrosis Program, St. Michael's Hospital, University of Toronto, Toronto, Canada.
  • Department of Paediatrics and Child Health, University of Cape Town, South Africa.
  • Cystic Fibrosis Canada, Toronto, Canada.
  • Department of Immunology, Institute for Cellular and Molecular Medicine, SAMRC Extramural Unit for Stem Cell Research and Therapy, University of Pretoria, South Africa.
  • Department of Basic Medical Sciences, The University of the West Indies, Mona, Jamaica.

Förderung

  • Harry Crossley Foundation
  • Cystic Fibrosis Foundation
  • National Research Foundation
  • South African Medical Research Council

Zitieren

APA

Zampoli, M., Sykes, J., Verstraete, J., Cheng, S. Y., Morrow, B., Pepper, M. S., Stewart, C., Zar, H. J., & Stephenson, A. L. (2024). Global disparities in cystic fibrosis outcomes prior to CFTR modulators: A CF registries cohort study in South Africa and Canada. Journal of Cystic Fibrosis, 23(2), 334-340. https://doi.org/10.1016/j.jcf.2023.09.003

Vancouver

Zampoli M, Sykes J, Verstraete J, Cheng SY, Morrow B, Pepper MS, et al. Global disparities in cystic fibrosis outcomes prior to CFTR modulators: A CF registries cohort study in South Africa and Canada. Journal of Cystic Fibrosis. 2024;23(2):334-340. doi:10.1016/j.jcf.2023.09.003

BibTeX
@article{Zampoli2024,
  author = {Zampoli, Marco and Sykes, Jenna and Verstraete, Janine and Cheng, Stephanie Y and Morrow, Brenda and Pepper, Michael S and Stewart, Cheryl and Zar, Heather J and Stephenson, Anne L},
  title = {Global disparities in cystic fibrosis outcomes prior to CFTR modulators: A CF registries cohort study in South Africa and Canada},
  journal = {Journal of Cystic Fibrosis},
  year = {2024},
  volume = {23},
  number = {2},
  pages = {334--340},
  doi = {10.1016/j.jcf.2023.09.003}
}
Kostenlos starten →